MedTrace Logo

Goal-directed Analgesia Using ANI During General Anesthesia in Children With Moyamoya Disease

NCT05672212 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-01-09

No results posted yet for this study

Summary

Analgesia Nociception Index (ANI) has been proposed for the evaluation of the nociception-antinociception balance in the perioperative period. In pediatric patients with Moyamoay disease, where the management of analgesia may be rendered difficult by pharmacological changes, we hypothesised that the monitoring of analgesia with ANI would reduce intraoperative opioid consumption during EDAS surgery.

Conditions

Interventions

DEVICE

ANI (Analgesia/Nociception Index) monitoring

Intraoperative analgesia was provided by injection of sufentanil, which was performed according to ANI monitor.

DEVICE

standard monitoring

Intraoperative analgesia was provided by injection of sufentanil, which was performed according to the clinician's assessment.

DRUG

Sufentanil

Sufentanil

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-04
Primary Completion
2025-01-04
Completion
2025-01-04

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05672212 on ClinicalTrials.gov